Monitor the company's ability to execute on its 2026 revenue guidance, particularly the ramp-up of scanner shipments and the initial revenue from its SaaS Cloud Platform. The new CPT code is a significant catalyst for future reimbursement and adoption.
Price Chart
Executive Summary
QT Imaging Holdings disclosed strong Q4 2025 financial results and 2026 guidance in an investor presentation, highlighting $8.3M in revenue (877% YoY growth), $18.9M annual revenue, and a projected $39M for 2026. Key catalysts include FDA breakthrough device designation, a new CPT code, and commercial partnerships in the US, Saudi Arabia, and UAE.
Key Facts
- Q4 2025 revenue was $8.3M, an 877% year-over-year increase.
- 2025 full-year revenue was $18.9M, surpassing guidance of $18.0M.
- 2026 revenue is projected to be approximately $39M.
- The company secured a Category III CPT code (X579T) for its breast imaging technology, effective January 1, 2027.
- The company has distribution agreements in the US (with NXC Imaging), Saudi Arabia (with Gulf Medical), and the UAE (with Al Naghi Medical).
- The company has a Breakthrough Device Designation from the FDA.
Financial Impact
Revenue is projected to nearly double from $18.9M in 2025 to $39M in 2026.
Risk Factors
- The company reported a net loss of $1.4M in Q4 2025, indicating it is not yet profitable.
- The gross margin declined to 38% in Q4 2025 from 47% in Q4 2024, which could pressure margins if costs remain high.
- The company's success is dependent on the commercial adoption of its technology and the reimbursement of its new CPT code.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-011625 |
| Document: qti-20260225.htm | 0001628280-26-011625 |
| Document: 0001628280-26-011625-index-headers.html | 0001628280-26-011625 |
| Document: 0001628280-26-011625-index.html | 0001628280-26-011625 |
| Document: 0001628280-26-011625.txt | 0001628280-26-011625 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 8w ago | 8-K | $2.77 $2.55 | ▼ −8.12% | ▼ −8.44% | $2.30 (−16.97%) |
Aug 18, 2026 9w ago | 8-K | $2.91 $2.69 | ▼ −7.56% | ▼ −6.57% | $2.30 (−20.96%) |
Jul 28, 2026 12w ago | 8-K | $2.71 $3.17 | ▲ +16.97% | ▲ +11.95% | $2.30 (−15.13%) |
Feb 25, 2026 34w ago | 8-K | $5.50 $6.30 | ▲ +14.55% | ▲ +20.96% | $2.30 (−58.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers